The United States National Institutes of Health announces the commencement of study. They Reveals, “on Wednesday, they starts with a mid-stage study. This is done to determine the risk of allergic reactions to COVID-19 vaccines.

See The Details!

The COVID-19 vaccines that are prepared by Moderna Inc (MRNA.O) and Pfizer Inc (PFE.N). As of reports, several incidents, including serious episodes as anaphlaxis are registered. These are inclining after vaccination of Pfizer/BioNTech and Moderna shots.

Center for Disease Prevention have given the statement in january. It said,”allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations.”


The study is sponsored by National Institute of Allergy & Infectious Disease. This study will enroll 3,400 adults. The adults between 18 Yrs to 69 Yrs. Approx 60% participant holds a history in allergic reactions. Reaction to Food, Immunotherapy or Insect stings.

The Aim for this study is to access the proportion of participants who have a systemic allergic reaction within 90 minutes after injection. The report Data is expected to release later this summer.

Source: Reuters

Image source : Pfizer


Comments are closed.